Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Cipla
Healthtrust
Julphar
UBS
Argus Health
Express Scripts

Generated: October 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019813

« Back to Dashboard

NDA 019813 describes DURAGESIC-75, which is a drug marketed by Janssen Pharms and is included in one NDA. It is available from four suppliers. Additional details are available on the DURAGESIC-75 profile page.

The generic ingredient in DURAGESIC-75 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Summary for 019813
Tradename:DURAGESIC-75
Applicant:Janssen Pharms
Ingredient:fentanyl
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019813
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 019813
Suppliers and Packaging for NDA: 019813
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DURAGESIC-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813 NDA Sandoz,Inc. 0781-7240 0781-7240-55 5 POUCH in 1 BOX (0781-7240-55) > 1 PATCH in 1 POUCH > 72 h in 1 PATCH
DURAGESIC-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813 NDA Sandoz,Inc. 0781-7241 0781-7241-55 5 POUCH in 1 BOX (0781-7241-55) > 1 PATCH in 1 POUCH > 72 h in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength100MCG/HR
Approval Date:Aug 7, 1990TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength75MCG/HR
Approval Date:Aug 7, 1990TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength50MCG/HR
Approval Date:Aug 7, 1990TE:ABRLD:Yes

Expired US Patents for NDA 019813

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms DURAGESIC-25 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813-004 Aug 7, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms DURAGESIC-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813-001 Aug 7, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms DURAGESIC-50 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813-003 Aug 7, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms DURAGESIC-50 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 019813-003 Aug 7, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Cantor Fitzgerald
Covington
Chubb
Queensland Health
Mallinckrodt
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.